Abstract
Previous studies showed that hydrolysates of β-lactoglobulin (BLG) prepared using gastrointestinal proteases strongly inhibit dipeptidyl peptidase-IV (DPP-IV) activity in vitro. In this study, we developed a BLG-secreting Lactococcus lactis strain as a delivery vehicle and in situ expression system. Interestingly, trypsin-digested recombinant BLG from L. lactis inhibited DPP-IV activity, suggesting that BLG-secreting L. lactis may be useful in the treatment of type 2 diabetes mellitus.
Cite
CITATION STYLE
Shigemori, S., Oshiro, K., Wang, P., Yamamoto, Y., Wang, Y., Sato, T., … Shimosato, T. (2014). Generation of Dipeptidyl Peptidase-IV-Inhibiting Peptides from β -Lactoglobulin Secreted by Lactococcus lactis. BioMed Research International, 2014. https://doi.org/10.1155/2014/393598
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.